# Lineage, Inc.: financial statements, quarterly

LINE · Nasdaq · CIK 1868159 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/line.md) · [Financials](/companies/line/financials.md) · [Filings](/companies/line/filings.md) · [Insiders](/companies/line/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/line/financials.md?period=annual).

## Income statement

| Line item | Unit | period not labelled (2023-09-30) | period not labelled (2023-12-31) | period not labelled (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1,329](/filings/0001868159-24-000018.md) | [1,334 d](/filings/0001868159-25-000011.md) | [1,328](/filings/0001868159-25-000061.md) | [1,338](/filings/0001868159-25-000095.md) | [1,335](/filings/0001868159-24-000018.md) | [1,339 d](/filings/0001868159-25-000011.md) | [1,292](/filings/0001868159-25-000061.md) | [1,350](/filings/0001868159-25-000095.md) | [1,377](/filings/0001868159-25-000110.md) | [1,336 d](/filings/0001868159-26-000012.md) | [1,297](/filings/0001868159-26-000028.md) | [1,361](/filings/0001868159-26-000039.md) |
| Cost of revenue | $m | [899](/filings/0001868159-24-000018.md) | [896 d](/filings/0001868159-26-000012.md) | [884](/filings/0001868159-25-000061.md) | [891](/filings/0001868159-25-000095.md) | [897](/filings/0001868159-25-000110.md) | [906 d](/filings/0001868159-26-000012.md) | [876](/filings/0001868159-26-000028.md) | [920](/filings/0001868159-26-000039.md) | [932](/filings/0001868159-25-000110.md) | [906 d](/filings/0001868159-26-000012.md) | [880](/filings/0001868159-26-000028.md) | [936](/filings/0001868159-26-000039.md) |
| Operating income | $m | [97.0](/filings/0001868159-24-000018.md) | [58.0 d](/filings/0001868159-26-000012.md) | [101](/filings/0001868159-25-000061.md) | [74.0](/filings/0001868159-25-000095.md) | [(515)](/filings/0001868159-25-000110.md) | [(21.0) d](/filings/0001868159-26-000012.md) | [56.0](/filings/0001868159-26-000028.md) | [23.0](/filings/0001868159-26-000039.md) | [35.0](/filings/0001868159-25-000110.md) | [67.0 d](/filings/0001868159-26-000012.md) | [36.0](/filings/0001868159-26-000028.md) | [54.0](/filings/0001868159-26-000039.md) |
| Interest expense | $m | [131](/filings/0001868159-24-000018.md) | [137 d](/filings/0001868159-26-000012.md) | [138](/filings/0001868159-25-000061.md) | [142](/filings/0001868159-25-000095.md) | [87.0](/filings/0001868159-25-000110.md) | [59.0 d](/filings/0001868159-26-000012.md) | [57.0](/filings/0001868159-26-000028.md) | [64.0](/filings/0001868159-26-000039.md) | [67.0](/filings/0001868159-25-000110.md) | [68.0 d](/filings/0001868159-26-000012.md) | [65.0](/filings/0001868159-26-000028.md) | [68.0](/filings/0001868159-26-000039.md) |
| Income tax | $m | [(5.0)](/filings/0001868159-24-000018.md) | [(6.0) d](/filings/0001868159-26-000012.md) | [(10.0)](/filings/0001868159-25-000061.md) | [7.0](/filings/0001868159-25-000095.md) | [(45.0)](/filings/0001868159-25-000110.md) | [(41.0) d](/filings/0001868159-26-000012.md) | [8.0](/filings/0001868159-26-000028.md) | [(7.0)](/filings/0001868159-26-000039.md) | [11.0](/filings/0001868159-25-000110.md) | [(14.0) d](/filings/0001868159-26-000012.md) | [4.0](/filings/0001868159-26-000028.md) | [(1.0)](/filings/0001868159-26-000039.md) |
| Net income | $m | [(39.0)](/filings/0001868159-24-000018.md) | [(51.0) d](/filings/0001868159-26-000012.md) | [(40.0)](/filings/0001868159-25-000061.md) | [(68.0)](/filings/0001868159-25-000095.md) | [(485)](/filings/0001868159-25-000110.md) | [(71.0) d](/filings/0001868159-26-000012.md) | [0.0](/filings/0001868159-26-000028.md) | [(6.0)](/filings/0001868159-26-000039.md) | [(100)](/filings/0001868159-25-000110.md) | [6.0 d](/filings/0001868159-26-000012.md) | [(46.0)](/filings/0001868159-26-000028.md) | [(29.0)](/filings/0001868159-26-000039.md) |
| Diluted EPS | $ per share | [(0.26)](/filings/0001868159-24-000018.md) | not reported | [(0.28)](/filings/0001868159-25-000061.md) | [(0.46)](/filings/0001868159-25-000095.md) | [(2.44)](/filings/0001868159-25-000110.md) | not reported | [0.01](/filings/0001868159-26-000028.md) | [(0.03)](/filings/0001868159-26-000039.md) | [(0.44)](/filings/0001868159-25-000110.md) | not reported | [(0.18)](/filings/0001868159-26-000028.md) | [(0.13)](/filings/0001868159-26-000039.md) |
| Basic EPS | $ per share | [(0.26)](/filings/0001868159-24-000018.md) | not reported | [(0.28)](/filings/0001868159-25-000061.md) | [(0.46)](/filings/0001868159-25-000095.md) | [(2.44)](/filings/0001868159-25-000110.md) | not reported | [0.01](/filings/0001868159-26-000028.md) | [(0.03)](/filings/0001868159-26-000039.md) | [(0.44)](/filings/0001868159-25-000110.md) | not reported | [(0.18)](/filings/0001868159-26-000028.md) | [(0.13)](/filings/0001868159-26-000039.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | period not labelled (2023-09-30) | period not labelled (2023-12-31) | period not labelled (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | not reported | [0.1](/filings/0001868159-25-000011.md) | not reported | [0.1](/filings/0001868159-24-000004.md) | [0.4](/filings/0001868159-24-000018.md) | [0.2](/filings/0001868159-25-000011.md) | not reported | not reported | not reported | not reported | not reported | not reported |
| Current assets | $bn | not reported | [1.3](/filings/0001868159-25-000011.md) | not reported | [1.3](/filings/0001868159-24-000004.md) | [1.6](/filings/0001868159-24-000018.md) | [1.3](/filings/0001868159-26-000012.md) | [1.4](/filings/0001868159-25-000061.md) | [1.3](/filings/0001868159-25-000095.md) | [1.3](/filings/0001868159-25-000110.md) | [1.2](/filings/0001868159-26-000039.md) | [1.3](/filings/0001868159-26-000028.md) | [1.2](/filings/0001868159-26-000039.md) |
| Total assets | $bn | not reported | [18.9](/filings/0001868159-25-000011.md) | not reported | [18.8](/filings/0001868159-24-000004.md) | [19.3](/filings/0001868159-24-000018.md) | [18.7](/filings/0001868159-26-000012.md) | [18.8](/filings/0001868159-25-000061.md) | [19.4](/filings/0001868159-25-000095.md) | [19.2](/filings/0001868159-25-000110.md) | [19.2](/filings/0001868159-26-000039.md) | [19.0](/filings/0001868159-26-000028.md) | [18.9](/filings/0001868159-26-000039.md) |
| Current liabilities | $bn | not reported | [1.4](/filings/0001868159-25-000011.md) | not reported | [1.2](/filings/0001868159-24-000004.md) | [1.5](/filings/0001868159-24-000018.md) | [1.5](/filings/0001868159-26-000012.md) | [1.4](/filings/0001868159-25-000061.md) | [1.4](/filings/0001868159-25-000095.md) | [1.3](/filings/0001868159-25-000110.md) | [1.5](/filings/0001868159-26-000039.md) | [1.5](/filings/0001868159-26-000028.md) | [1.6](/filings/0001868159-26-000039.md) |
| Total liabilities | $bn | not reported | [12.8](/filings/0001868159-25-000011.md) | not reported | [13.0](/filings/0001868159-24-000004.md) | [9.1](/filings/0001868159-24-000018.md) | [9.0](/filings/0001868159-26-000012.md) | [9.1](/filings/0001868159-25-000061.md) | [9.8](/filings/0001868159-25-000095.md) | [9.8](/filings/0001868159-25-000110.md) | [9.9](/filings/0001868159-26-000039.md) | [10.0](/filings/0001868159-26-000028.md) | [10.0](/filings/0001868159-26-000039.md) |
| Long-term debt | $bn | not reported | [9.0](/filings/0001868159-25-000011.md) | not reported | [9.3](/filings/0001868159-24-000004.md) | [5.0](/filings/0001868159-24-000018.md) | [4.9](/filings/0001868159-26-000012.md) | [5.1](/filings/0001868159-25-000061.md) | [5.7](/filings/0001868159-25-000095.md) | [5.9](/filings/0001868159-25-000110.md) | [6.1](/filings/0001868159-26-000039.md) | [6.3](/filings/0001868159-26-000028.md) | [6.2](/filings/0001868159-26-000039.md) |
| Current portion of debt | $bn | not reported | [0.0](/filings/0001868159-25-000011.md) | not reported | [0.0](/filings/0001868159-24-000004.md) | [0.0](/filings/0001868159-24-000018.md) | [0.1](/filings/0001868159-26-000012.md) | [0.1](/filings/0001868159-25-000061.md) | [0.0](/filings/0001868159-25-000095.md) | [0.0](/filings/0001868159-25-000110.md) | [0.0](/filings/0001868159-26-000039.md) | [0.0](/filings/0001868159-26-000028.md) | [0.0](/filings/0001868159-26-000039.md) |
| Shareholders' equity | $bn | [5.8](/filings/0001868159-24-000018.md) | [5.1](/filings/0001868159-25-000011.md) | [5.6](/filings/0001868159-25-000110.md) | [4.9](/filings/0001868159-24-000004.md) | [9.0](/filings/0001868159-24-000018.md) | [8.6](/filings/0001868159-26-000012.md) | [8.6](/filings/0001868159-25-000061.md) | [8.6](/filings/0001868159-25-000095.md) | [8.4](/filings/0001868159-25-000110.md) | [8.2](/filings/0001868159-26-000039.md) | [8.1](/filings/0001868159-26-000028.md) | [7.9](/filings/0001868159-26-000039.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest, us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | period not labelled (2023-09-30) | period not labelled (2023-12-31) | period not labelled (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [229 d](/filings/0001868159-24-000018.md) | [231 d](/filings/0001868159-26-000012.md) | [105](/filings/0001868159-25-000061.md) | [155 d](/filings/0001868159-25-000095.md) | [186 d](/filings/0001868159-25-000110.md) | [257 d](/filings/0001868159-26-000012.md) | [139](/filings/0001868159-26-000028.md) | [258 d](/filings/0001868159-26-000039.md) | [230 d](/filings/0001868159-25-000110.md) | [316 d](/filings/0001868159-26-000012.md) | [130](/filings/0001868159-26-000028.md) | [311 d](/filings/0001868159-26-000039.md) |
| Capital expenditure | $m | [177 d](/filings/0001868159-24-000018.md) | [161 d](/filings/0001868159-26-000012.md) | [147](/filings/0001868159-25-000061.md) | [186 d](/filings/0001868159-25-000095.md) | [153 d](/filings/0001868159-25-000110.md) | [205 d](/filings/0001868159-26-000012.md) | [151](/filings/0001868159-26-000028.md) | [163 d](/filings/0001868159-26-000039.md) | [195 d](/filings/0001868159-25-000110.md) | [238 d](/filings/0001868159-26-000012.md) | [185](/filings/0001868159-26-000028.md) | [125 d](/filings/0001868159-26-000039.md) |
| Dividends paid | $m | [0.0 d](/filings/0001868159-24-000018.md) | [46.0 d](/filings/0001868159-26-000012.md) | [112](/filings/0001868159-25-000061.md) | [11.0 d](/filings/0001868159-25-000095.md) | [15.0 d](/filings/0001868159-25-000110.md) | [96.0 d](/filings/0001868159-26-000012.md) | [134](/filings/0001868159-26-000028.md) | [134 d](/filings/0001868159-26-000039.md) | [134 d](/filings/0001868159-25-000110.md) | [135 d](/filings/0001868159-26-000012.md) | [133](/filings/0001868159-26-000028.md) | [136 d](/filings/0001868159-26-000039.md) |
| Share repurchases | $m | [0.0 d](/filings/0001868159-24-000018.md) | [9.0 d](/filings/0001868159-26-000012.md) | [25.0](/filings/0001868159-25-000061.md) | [0.0 d](/filings/0001868159-25-000095.md) | [0.0 d](/filings/0001868159-25-000110.md) | [17.0 d](/filings/0001868159-26-000012.md) | [0.0](/filings/0001868159-25-000061.md) | [0.0 d](/filings/0001868159-25-000095.md) | [0.0 d](/filings/0001868159-25-000110.md) | [82.0 d](/filings/0001868159-26-000012.md) | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | period not labelled (2023-06-30) | period not labelled (2023-09-30) | period not labelled (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [162](/filings/0001868159-24-000004.md) | [162](/filings/0001868159-24-000018.md) | [162](/filings/0001868159-25-000061.md) | [162](/filings/0001868159-25-000095.md) | [210](/filings/0001868159-25-000110.md) | [228](/filings/0001868159-26-000028.md) | [229](/filings/0001868159-26-000039.md) | [228](/filings/0001868159-25-000110.md) | [227](/filings/0001868159-26-000028.md) | [228](/filings/0001868159-26-000039.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 227,710,012 at 2026-07-30, from the cover of the [10-Q filed 2026-08-05](/filings/0001868159-26-000039.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:49 ET. No prices; not investment advice.